检索结果 - Karthikeyan Murugesan

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
    Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma

    Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma 由 Gajanan Kendre, Karthikeyan Murugesan, Tilman Brummer, Oreste Segatto, Anna Saborowski, Arndt Vogel

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    PD-L1 gene amplification and focality: relationship with protein expression

    PD-L1 gene amplification and focality: relationship with protein expression 由 Denis L. Jardim, Karthikeyan Murugesan, Julia A. Elvin, Richard S.P. Huang, Razelle Kurzrock

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    <i>GNAS, GNAQ,</i>and<i>GNA11</i>alterations in patients with diverse cancers

    <i>GNAS, GNAQ,</i>and<i>GNA11</i>alterations in patients with diverse cancers 由 Austin J. Parish, Vi Nguyen, Aaron M. Goodman, Karthikeyan Murugesan, Garrett M. Frampton, Razelle Kurzrock

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Targeting Notch signalling pathway of cancer stem cells

    Targeting Notch signalling pathway of cancer stem cells 由 Vandana Venkatesh, Raghu Nataraj, Gopenath Thangaraj, Karthikeyan Murugesan, Ashok Gnanasekaran, Shanmukhappa Kaginelli, Kuppannan Gobianand, Chandrashekrappa Gowdru Kallappa, Kanthesh M. Basalingappa

    出版 2018
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Targeting Notch signalling pathway of cancer stem cells

    Targeting Notch signalling pathway of cancer stem cells 由 Venkatesh, Vandana, Nataraj, Raghu, Thangaraj, Gopenath S., Karthikeyan, Murugesan, Gnanasekaran, Ashok, Kaginelli, Shanmukhappa B., Kuppanna, Gobianand, Kallappa, Chandrashekrappa Gowdru, Basalingappa, Kanthesh M.

    出版 2018
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  6. 6
    PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers

    PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers 由 Mark Yarchoan, Lee A. Albacker, Alexander C. Hopkins, Meagan Montesion, Karthikeyan Murugesan, Teena Vithayathil, Neeha Zaidi, Nilofer S. Azad, Daniel A. Laheru, Garrett M. Frampton, Elizabeth M. Jaffee

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases

    Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases 由 Richard S.P. Huang, Lukas Harries, Brennan Decker, Matthew Hiemenz, Karthikeyan Murugesan, James Creeden, Khaled A. Tolba, Laura P. Stabile, Shakti Ramkissoon, Timothy F. Burns, Jeffrey S. Ross

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns

    Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns 由 Mason A. Israel, Natalie Danziger, Kimberly McGregor, Karthikeyan Murugesan, Ole Gjoerup, Ethan S. Sokol, Hanna Tukachinsky, Razelle Kurzrock, Shumei Kato, Jason K. Sicklick, Halla Nimeiri, Geoffrey R. Oxnard, Jeffrey S. Ross

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    <i>KRAS</i> Allelic Variants in Biliary Tract Cancers

    <i>KRAS</i> Allelic Variants in Biliary Tract Cancers 由 Gordon Taylor Moffat, Zishuo Ian Hu, Funda Meric‐Bernstam, Elisabeth Kong, Dean Pavlick, Jeffrey S. Ross, Karthikeyan Murugesan, Lawrence N. Kwong, Anaemy Danner De Armas, Anil Korkut, Milind Javle, Jennifer J. Knox

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations

    Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations 由 Karthikeyan Murugesan, Andrea Necchi, Timothy C. Burn, Ole Gjoerup, R. Greenstein, Melanie A. Krook, Jorge-Antonio Lopez, Meagan Montesion, Halla Nimeiri, A.R. Parikh, Sameek Roychowdhury, S. Schwemmers, Ian M. Silverman, Arndt Vogel

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis

    Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis 由 Richard S.P. Huang, David P. Carbone, Gerald Li, Alexa B. Schrock, Ryon P. Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S. Ross, Khaled A. Tolba, Jacob Sands, Geoffrey R. Oxnard, David R. Spigel

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer

    Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer 由 Smruthy Sivakumar, Dexter X. Jin, Hanna Tukachinsky, Karthikeyan Murugesan, Kimberly McGregor, Natalie Danziger, Dean C. Pavlick, Ole Gjoerup, Jeffrey S. Ross, Robert J. Harmon, Jon Chung, Brennan Decker, Lucas Dennis, Garrett M. Frampton, Luciana Molinero, Steffi Oesterreich, Jeffrey M. Venstrom, Geoffrey R. Oxnard, Priti S. Hegde, Ethan Sokol

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response

    Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response 由 Meagan Montesion, Karthikeyan Murugesan, Dexter X. Jin, Radwa Sharaf, Nora Sánchez, Ameet Guria, Max Minker, Gerald Li, Virginia Fisher, Ethan S. Sokol, Dean C. Pavlick, Jay A. Moore, Alan Braly, Gaurav Singal, David Fabrizio, Leah A. Comment, Naiyer A. Rizvi, Brian M. Alexander, Garrett M. Frampton, Priti S. Hegde, Lee A. Albacker

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer

    Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer 由 Craig Furman, Xiaoling Puyang, Zhaojie Zhang, Zhenhua J. Wu, Deepti Banka, Kiran Aithal, Lee A. Albacker, Ming‐Hong Hao, Sean Irwin, Amy Kim, Meagan Montesion, Alyssa Moriarty, Karthikeyan Murugesan, Tuong-Vi Nguyen, Victoria Rimkunas, Tarek Sahmoud, Michael J. Wick, Shihua Yao, Xun Zhang, Hao Zeng, Frédéric H. Vaillancourt, David M. Bolduc, Nicholas Larsen, Guo Zhu Zheng, Sudeep Prajapati, Ping Zhu, Manav Korpal

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

    Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer 由 Marcelo V. Negrão, Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bāra, Vincent K. Shen, Hao Xu, Sylvia Hu, Dawen Sui, Yasir Y. Elamin, Xiuning Le, Michael E. Goldberg, Karthikeyan Murugesan, Chang‐Jiun Wu, Jianhua Zhang, David S Barreto, Jacqulyne Robichaux, Alexandre Reuben, Tina Cascone, Carl M. Gay, K. G. Mitchell, Lingzhi Hong, Waree Rinsurongkawong, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, Anne S. Tsao, Vassiliki A. Papadimitrakopoulou, Don L. Gibbons, Bonnie S. Glisson, Gaurav Singal, Vincent A. Miller, Brian M. Alexander, Garrett M. Frampton, Lee A. Albacker, David S. Shames, Jianjun Zhang, John V. Heymach

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: